Implementing Generalized Additive Models to Estimate the Expected Value of Sample Information in a Microsimulation Model: Results of Three Case Studies

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Medical decision making

• Publication date

  2017-11-09

• Fields of study

  Medicine, Mathematics, Economics

• Identifiers
  DOI 10.1177/0272989X17732973PMID 29117791PMCID PMC5771838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa

  2017cited by this paper
• International AIDS Society global scientific strategy: towards an HIV cure 2016

  2016cited by this paper
• An Efficient Estimator for the Expected Value of Sample Information

  2016cited by this paper
• Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling

  2015cited by this paper
• Tenofovir-based preexposure prophylaxis for HIV infection among African women.

  2015cited by this paper
• Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection

  2015cited by this paper
• Progress toward curing HIV infections with hematopoietic stem cell transplantation.

  2015cited by this paper
• Value of Information

  2015cited by this paper
• Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample

  2015cited by this paper
• Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US

  2015cited by this paper
• HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

  2014cited by this paper
• Strategies for Efficient Computation of the Expected Value of Partial Perfect Information

  2014cited by this paper
• Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample

  2013cited by this paper
• Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.

  2013cited by this paper
• Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

  2013cited by this paper
• Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

  2012cited by this paper
• Preexposure prophylaxis for HIV infection among African women.

  2012cited by this paper
• Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

  2012cited by this paper
• Cost Effectiveness of the National HIV/AIDS Strategy Goal of Increasing Linkage to Care for HIV-Infected Persons

  2012cited by this paper
• Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

  2012cited by this paper
• mgcv:Mixed GAM Computation Vehicle with GCV/AIC/REML smoothness estimation

  2012cited by this paper
• Estimating Expected Value of Sample Information for Incomplete Data Models Using Bayesian Approximation

  2011cited by this paper
• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

  2010cited by this paper
• Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

  2010cited by this paper
• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women: Supporting Online Material

  2010cited by this paper
• Efficient computation of partial expected value of sample information using Bayesian approximation.

  2007cited by this paper
• Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

  2006cited by this paper
• The value of medical spending in the United States, 1960-2000.

  2006cited by this paper
• Value of Medical Innovation in the United States: 1960-2000

  2006cited by this paper
• Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

  2005cited by this paper
• Expected Value of Sample Information Calculations in Medical Decision Modeling

  2004cited by this paper
• Generalized Additive Models

  1986cited by this paper

• The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis

  2023cites this paper
• CHEERS Value of Information (CHEERS-VOI) Reporting Standards - Explanation and Elaboration.

  2023cites this paper
• A unified approach for outliers and influential data detection: The value of information in retrospect

  2021cites this paper
• Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.

  2020cites this paper
• Practical metrics for establishing the health benefits of research to support research prioritisation

  2020cites this paper
• Health economic modeling to optimize the HIV care continuum: methods and applications

  2020cites this paper
• The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis

  2019cites this paper
• Setting research priorities in Global Health:Appraising the value of evidence generation activities to support decision-making in health care

  2018cites this paper
• The Value of Information in Retrospect

  2018cites this paper